-+ 0.00%
-+ 0.00%
-+ 0.00%

PULMOVANT ANNOUNCES POSITIVE RESULTS FROM PHOCUS STUDY OF MOSLICIGUAT IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE (PH-ILD) AND UNVEILS ONGOING PHASE 3 PHRONTIER STUDY

路透·09/08/2026 10:00:01

登录查看新闻详情